LPA and type 2 diabetes mellitus: By using an extended biomarker dataset in over 450,000 UK Biobank participants, we confirmed epidemiological observation of the higher risk of T2D in individuals with very low Lp(a) concentrations (<3.8 nmol/L) contrasting its protective effect on CVDs.